Gene knockout cell lines are genetically engineered using CRISPR-Cas9 technology to precisely disrupt target genes at the genomic level, resulting in complete loss of gene function. These cell models are widely used in gene function studies, signaling pathway analysis, disease mechanism research, and drug target validation. Ubigene has developed a portfolio of over 8,000 gene knockout cell lines, covering major cell types and high-interest targets, enabling rapid support for diverse research needs.

is generated by targeted disruption of the gene in cells. This cell line is designed to facilitate investigation of function in cellular processes, gene regulation, and its involvement in disease-related pathways.The gene knockout cell is validated by Sanger sequencing, and each clone is accompanied by STR authentication documentation. The product is delivered as a homozygous single-cell clone with stable passaging capability. It is guaranteed to be mycoplasma-free and exhibits high viability. In addition, comprehensive technical support and complimentary cell culture guidance are provided throughout use.